PERNIX THERAPEUTICS HLDGS IN's ticker is and the CUSIP is 71426VAK4. A total of 13 filers reported holding PERNIX THERAPEUTICS HLDGS IN in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2018 | $2,545,000 | -3.2% | 6,000,000 | 0.0% | 0.15% | +25.6% |
Q3 2018 | $2,628,000 | +0.4% | 6,000,000 | 0.0% | 0.12% | +19.8% |
Q2 2018 | $2,618,000 | -5.6% | 6,000,000 | 0.0% | 0.10% | -23.5% |
Q1 2018 | $2,772,000 | +9.6% | 6,000,000 | 0.0% | 0.13% | -19.5% |
Q4 2017 | $2,530,000 | +0.2% | 6,000,000 | 0.0% | 0.16% | -16.3% |
Q3 2017 | $2,526,000 | +35.9% | 6,000,000 | 0.0% | 0.20% | -16.6% |
Q2 2017 | $1,859,000 | +12.6% | 6,000,000 | 0.0% | 0.24% | +11.4% |
Q1 2017 | $1,651,000 | +11.6% | 6,000,000 | 0.0% | 0.21% | -29.4% |
Q4 2016 | $1,479,000 | -27.9% | 6,000,000 | -14.3% | 0.30% | -16.9% |
Q3 2016 | $2,050,000 | +37.9% | 7,000,000 | 0.0% | 0.36% | +9.1% |
Q2 2016 | $1,487,000 | – | 7,000,000 | – | 0.33% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Telemetry Investments, L.L.C. | 10,000,000 | $4,000,000 | 1.43% |
ARMISTICE CAPITAL, LLC | 21,760,000 | $9,161,000 | 1.08% |
Broadfin Capital, LLC | 15,000,000 | $5,983,000 | 0.88% |
Avoro Capital Advisors LLC | 6,000,000 | $2,526,000 | 0.20% |
Bruce & Co., Inc. | 2,000,000 | $800,000 | 0.18% |
Aisling Capital LLC | 2,500,000 | $1,053,000 | 0.17% |
TENOR CAPITAL MANAGEMENT Co., L.P. | 2,000,000 | $862,000 | 0.07% |
BARINGS LLC | 7,500,000 | $3,000,000 | 0.05% |
ZAZOVE ASSOCIATES LLC | 2,000,000 | $831,000 | 0.04% |
Perceptive Advisors | 2,000,000 | $840,000 | 0.02% |